FDA Limits Use of J & J COVID-19 Vaccine Due to Blood Clot Risk

FRIDAY, May 6, 2022 -- Citing the accumulated data on a raised risk for thrombosis with thrombocytopenia syndrome (TTS), the U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson& Johnson COVID-19...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news